Equities research analysts expect that Cerner Co. (NASDAQ:CERN) will post sales of $1.34 billion for the current quarter, Zacks reports. Five analysts have provided estimates for Cerner’s earnings, with the highest sales estimate coming in at $1.35 billion and the lowest estimate coming in at $1.33 billion. Cerner reported sales of $1.26 billion during the same quarter last year, which would suggest a positive year over year growth rate of 6.3%. The firm is expected to report its next quarterly earnings report on Thursday, April 26th.

On average, analysts expect that Cerner will report full year sales of $1.34 billion for the current year, with estimates ranging from $5.51 billion to $5.60 billion. For the next fiscal year, analysts expect that the company will report sales of $6.04 billion per share, with estimates ranging from $5.94 billion to $6.14 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that that provide coverage for Cerner.

Cerner (NASDAQ:CERN) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.58 earnings per share for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.03). The firm had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Cerner had a net margin of 16.86% and a return on equity of 17.25%. The business’s quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the business earned $0.61 earnings per share.

CERN has been the topic of several research analyst reports. Piper Jaffray Companies restated a “buy” rating and set a $77.00 target price on shares of Cerner in a research report on Thursday, October 12th. Jefferies Group set a $79.00 target price on shares of Cerner and gave the stock a “buy” rating in a research report on Friday, October 13th. Zacks Investment Research upgraded shares of Cerner from a “hold” rating to a “buy” rating and set a $81.00 target price on the stock in a research report on Tuesday, October 17th. SunTrust Banks restated a “buy” rating and set a $79.00 target price on shares of Cerner in a research report on Thursday, October 19th. Finally, Royal Bank of Canada restated a “buy” rating on shares of Cerner in a research report on Wednesday, October 25th. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and nine have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $65.89.

In related news, CEO Clifford W. Illig sold 140,000 shares of the business’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $65.52, for a total value of $9,172,800.00. Following the completion of the transaction, the chief executive officer now owns 1,229,719 shares of the company’s stock, valued at approximately $80,571,188.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Michael R. Battaglioli sold 4,000 shares of the business’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $69.89, for a total transaction of $279,560.00. Following the completion of the transaction, the vice president now directly owns 4,000 shares of the company’s stock, valued at approximately $279,560. The disclosure for this sale can be found here. Insiders have sold a total of 784,000 shares of company stock valued at $51,926,960 in the last ninety days. Corporate insiders own 13.11% of the company’s stock.

A number of hedge funds have recently made changes to their positions in the stock. Laurel Wealth Advisors Inc. raised its stake in Cerner by 0.6% in the 2nd quarter. Laurel Wealth Advisors Inc. now owns 3,909 shares of the company’s stock valued at $259,000 after purchasing an additional 24 shares during the last quarter. Advisory Services Network LLC raised its stake in Cerner by 4.4% in the 2nd quarter. Advisory Services Network LLC now owns 1,648 shares of the company’s stock valued at $110,000 after purchasing an additional 70 shares during the last quarter. EagleClaw Capital Managment LLC raised its stake in Cerner by 0.4% in the 2nd quarter. EagleClaw Capital Managment LLC now owns 26,050 shares of the company’s stock valued at $1,734,000 after purchasing an additional 100 shares during the last quarter. Raymond James Financial Services Advisors Inc. raised its stake in Cerner by 1.9% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 16,515 shares of the company’s stock valued at $1,098,000 after purchasing an additional 302 shares during the last quarter. Finally, Thrivent Financial For Lutherans raised its stake in Cerner by 3.1% in the 2nd quarter. Thrivent Financial For Lutherans now owns 11,110 shares of the company’s stock valued at $738,000 after purchasing an additional 330 shares during the last quarter. 81.99% of the stock is owned by hedge funds and other institutional investors.

Shares of Cerner (NASDAQ:CERN) traded down $1.13 during midday trading on Thursday, hitting $62.35. 554,479 shares of the company’s stock traded hands, compared to its average volume of 2,393,575. The stock has a market cap of $21,271.23, a price-to-earnings ratio of 24.36, a P/E/G ratio of 1.88 and a beta of 0.90. Cerner has a 52 week low of $51.26 and a 52 week high of $73.86. The company has a quick ratio of 2.75, a current ratio of 2.77 and a debt-to-equity ratio of 0.11.

ILLEGAL ACTIVITY NOTICE: This report was first posted by Daily Political and is the property of of Daily Political. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at https://www.dailypolitical.com/2018/02/08/analysts-expect-cerner-co-cern-will-post-quarterly-sales-of-1-34-billion.html.

Cerner Company Profile

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Get a free copy of the Zacks research report on Cerner (CERN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.